Yi D, Li T, Xiao Y, Zhang X, Hao Q, Zhang F
Bioeng Transl Med. 2025; 10(2):e10728.
PMID: 40060755
PMC: 11883108.
DOI: 10.1002/btm2.10728.
Spring J, Gurbuxani S, Golovkina T
mBio. 2025; 16(3):e0386624.
PMID: 39969175
PMC: 11898629.
DOI: 10.1128/mbio.03866-24.
Li Q, Geng S, Luo H, Wang W, Mo Y, Luo Q
Signal Transduct Target Ther. 2024; 9(1):266.
PMID: 39370455
PMC: 11456611.
DOI: 10.1038/s41392-024-01953-7.
Gong D, Adomako-Bonsu A, Wang M, Li J
PeerJ. 2023; 11:e15777.
PMID: 37554340
PMC: 10405800.
DOI: 10.7717/peerj.15777.
Niekamp P, Kim C
Gut Liver. 2023; 17(2):190-203.
PMID: 36632785
PMC: 10018301.
DOI: 10.5009/gnl220260.
Identification of Streptococcus gallolyticus in tumor samples of Iranian patients diagnosed with colorectal cancer.
Kamali N, Talebi Bezmin Abadi A, Abadi B, Rahimi F, Forootan M
BMC Res Notes. 2022; 15(1):316.
PMID: 36199123
PMC: 9532806.
DOI: 10.1186/s13104-022-06207-9.
The Microbiome-Immune Axis Therapeutic Effects in Cancer Treatments.
Son Y, Kim J
J Microbiol Biotechnol. 2022; 32(9):1086-1097.
PMID: 36116940
PMC: 9628962.
DOI: 10.4014/jmb.2208.08002.
Gut commensal bacteria enhance pathogenesis of a tumorigenic murine retrovirus.
Spring J, Khan A, Lara S, OGrady K, Wilks J, Gurbuxani S
Cell Rep. 2022; 40(11):111341.
PMID: 36103821
PMC: 10226680.
DOI: 10.1016/j.celrep.2022.111341.
Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora.
Sadrekarimi H, Gardanova Z, Bakhshesh M, Ebrahimzadeh F, Fakhre Yaseri A, Thangavelu L
J Transl Med. 2022; 20(1):301.
PMID: 35794566
PMC: 9258144.
DOI: 10.1186/s12967-022-03492-7.
An Integrative Approach to Characterize the Early Phases of Dimethylhydrazine-Induced Colorectal Carcinogenesis in the Rat.
Silva-Reis R, Castro-Ribeiro C, Goncalves M, Ferreira T, Pires M, Iglesias-Aguirre C
Biomedicines. 2022; 10(2).
PMID: 35203618
PMC: 8962270.
DOI: 10.3390/biomedicines10020409.
Shifting the Focus of Signaling Abnormalities in Colon Cancer.
Brown M, Ried T
Cancers (Basel). 2022; 14(3).
PMID: 35159051
PMC: 8834070.
DOI: 10.3390/cancers14030784.
Potential Role of the Gut Microbiome In Colorectal Cancer Progression.
Kim J, Lee H
Front Immunol. 2022; 12:807648.
PMID: 35069592
PMC: 8777015.
DOI: 10.3389/fimmu.2021.807648.
It takes a village: microbiota, parainflammation, paligenosis and bystander effects in colorectal cancer initiation.
Wang X, Undi R, Ali N, Huycke M
Dis Model Mech. 2021; 14(5).
PMID: 33969420
PMC: 10621663.
DOI: 10.1242/dmm.048793.
Spontaneous and Induced Tumors in Germ-Free Animals: A General Review.
Mishra R, Rajsiglova L, Lukac P, Tenti P, Sima P, caja F
Medicina (Kaunas). 2021; 57(3).
PMID: 33799911
PMC: 8002107.
DOI: 10.3390/medicina57030260.
The Microbiome and Its Implications in Cancer Immunotherapy.
Choudhry H
Molecules. 2021; 26(1).
PMID: 33401586
PMC: 7795182.
DOI: 10.3390/molecules26010206.
The Intestinal Microbiota and Colorectal Cancer.
Cheng Y, Ling Z, Li L
Front Immunol. 2020; 11:615056.
PMID: 33329610
PMC: 7734048.
DOI: 10.3389/fimmu.2020.615056.
Role of Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/ Polyps with Dysplasia.
Fujiwara-Tani R, Fujii K, Mori S, Kishi S, Sasaki T, Ohmori H
Int J Mol Sci. 2020; 21(11).
PMID: 32481659
PMC: 7313056.
DOI: 10.3390/ijms21113840.
Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?.
Tarashi S, Siadat S, Ahmadi Badi S, Zali M, Biassoni R, Ponzoni M
Microorganisms. 2019; 7(11).
PMID: 31766208
PMC: 6920974.
DOI: 10.3390/microorganisms7110561.
Role of Microbiome in Modulating Immune Responses in Cancer.
Bose M, Mukherjee P
Mediators Inflamm. 2019; 2019:4107917.
PMID: 31308831
PMC: 6594313.
DOI: 10.1155/2019/4107917.
The role of intestinal microbiota in the pathogenesis of colorectal carcinoma.
Kuzma J, Chmelar D, Hajek M, Lochmanova A, ciznar I, Rozloznik M
Folia Microbiol (Praha). 2019; 65(1):17-24.
PMID: 31001762
DOI: 10.1007/s12223-019-00706-2.